In addition to this, the advent of simpler, as well as less time-consuming lead discovery techniques, is expected to boost the global FBDD market remarkably in the coming years. The streamlined and easy access to highly advanced biophysical techniques is also projected to add substantially to the growth of this market in the near future.
Latest Activities by Key Players in Global FBDD Market
- Astex has recently become a partner in the Dementia Consortium. The company is looking forward to applying its expertise in fragment-based drug design to this venture.
- Nuevolution, a Denmark-based company operating in small molecule drug discovery, has announced its partnership with Janssen Biotech Inc., a subsidiary of Johnson and Johnson. According to the partnership agreement, Nuevolution will utilize ‘Chemetics’, its drug discovery platform, to discover and develop drug candidates against the drug targets picked out by Janssen.